eToro - Investment and Trading Platform Home Page
SearchSearch
Languages
Language
LoginSign up
Login
Stocks-CRSP-CRISPR Therapeutics AG

CRISPR Therapeutics AG CRSP

‎$‎61.671.35(2.24%)(1D)
• Delayed prices by Nasdaq • in USD
Invest in CRISPR Therapeutics AG
Today
Create an eToro account to buy CRSP stock on a secure, user-friendly, multi-asset trading platform.
Buy CRISPR Therapeutics AG
Buy CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Buy CRSP
Analyst Forecast
i
This 12-month forecast is based on a composite of analyst projections. Based on analysts with a rating of 4+ stars. This is not a prediction made by eToro nor is it investment advice.
Consensus
Moderate Buy
Price Target
82.25
Based on analysts who covered CRSP

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

CRISPR Therapeutics AG News

More about CRISPR Therapeutics AG
With headquarters in Zug, Switzerland, CRISPR Therapeutics AG (CRSP) is a gene-editing company. Founded in 2013, the firm develops gene-based medicines to treat patients with serious diseases. As of August 2020, the company was working on other programmes, including hemoglobinopathies, immuno-oncology, regenerative medicine and in vivo approaches. The company has offices in San Francisco, California and Cambridge, Massachusetts in the US, as well as an office in Switzerland and a business office in London.

Trading on the NASDAQ stock exchange, the ticker CRSP has been assigned to CRISPR Therapeutics AG. From October 2016 to August 2020, the CRSP share price reached a low of $11.63 (February 2017) and rose to a high of $97.82 (July 2020).

The company makes use of CRISPR/Cas9 gene-editing technology to modify, delete or correct specific regions of human DNA. This technology was co-invented by Dr Emmanuelle Charpentier, one of CRISPR Therapeutics AG's scientific founders. Genes are edited by precisely cutting DNA and allowing natural DNA repair processes to complete the job. CRISPR Therapeutics AG's lead programme targets β-thalassemia and sickle cell disease. It entered clinical testing in August 2020.

Track the CRSP instrument by adding it to your eToro watchlist now and diversify your portfolio with this medical research company.
VIEW MORE   

CRSP Stock Price Chart

‎12.56‎
Past Month
1D
1W
1M
6M
1Y
3Y
MAX
Sign up for full charts powered byTradingView logo
*Past performance is not an indication of future results
Asset negative trend

The CRISPR Therapeutics AG share price is on the decline this week.

i
A ‘rising’ price indicates that the weekly price has increased by more than 0.5%.
A price ‘on the decline’ indicates that the weekly price has decreased by more than 0.5%.
A ‘stable’ price indicates that the change in weekly price is between -0.5% and 0.5%.
The CRISPR Therapeutics AG share price today is ‎$‎61.67, reflecting a ‎2.24‎% change over the last 24 hours and ‎-1.01‎% over the past week. The current market capitalization of CRSP is ‎$‎5.61B with an average volume in the last three months of 3.14M. The stock has a P/E ratio of -11.37 and a dividend yield of 0%. With the stock’s beta sitting at 1.53
Market Cap
i
Total value of all asset shares, calculated by multiplying the price by the total number of outstanding shares.
‎$‎5.61B
Day’s Range
i
Shows the high and low prices of the day.
‎$‎58.36 - ‎$‎61.58
52W Range
i
Shows the high and low prices of the last year.
‎$‎29.96 - ‎$‎72.94
Average Volume (3M)
i
The average number of shares traded per day over the last three months.
3.14M
Price-Earnings Ratio
i
The result of this asset’s share price divided by its earnings per share.
-11.37
Revenue
i
The total income generated by this company’s goods and services last year.
‎$‎38.05M
Dividend (Yield)
i
How much a company pays out in dividends each year relative to its stock price.
‎$‎0 (0%)
Prev Close
i
The final price of this asset at the end of the last trading day.
‎$‎61.67
EPS
i
A company’s total earnings divided by the number of shares it has issued.
‎$‎-5.42
Beta
i
A measure of whether any asset does, or doesn’t, experience price moves in line with the broader market.
1.53
What Is CRISPR Therapeutics AG?
With headquarters in Zug, Switzerland, CRISPR Therapeutics AG (CRSP) is a gene-editing company. Founded in 2013, the firm develops gene-based medicines to treat patients with serious diseases. As of August 2020, the company was working on other programmes, including hemoglobinopathies, immuno-oncology, regenerative medicine and in vivo approaches. The company has offices in San Francisco, California and Cambridge, Massachusetts in the US, as well as an office in Switzerland and a business office in London.

Trading on the NASDAQ stock exchange, the ticker CRSP has been assigned to CRISPR Therapeutics AG. From October 2016 to August 2020, the CRSP share price reached a low of $11.63 (February 2017) and rose to a high of $97.82 (July 2020).

The company makes use of CRISPR/Cas9 gene-editing technology to modify, delete or correct specific regions of human DNA. This technology was co-invented by Dr Emmanuelle Charpentier, one of CRISPR Therapeutics AG's scientific founders. Genes are edited by precisely cutting DNA and allowing natural DNA repair processes to complete the job. CRISPR Therapeutics AG's lead programme targets β-thalassemia and sickle cell disease. It entered clinical testing in August 2020.

Track the CRSP instrument by adding it to your eToro watchlist now and diversify your portfolio with this medical research company.
CEO
Samarth Kulkarni, PhD
Employees
393
Founded
2013
HQ
Zug, Zug, CH
Med Tech
NASDAQ
Buy CRSP

How can I buy CRISPR Therapeutics AG stocks?

To purchase CRISPR Therapeutics AG:
01

Create an eToro account:

Sign up for an eToro account and verify your identity.
02

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.
03

Search and purchase:

Search the CRISPR Therapeutics AG (CRSP) page and place an order to buy CRISPR Therapeutics AG.
Buy CRSP
Looking for more information? Check out our guide on Academy.
Top Guides
Our top picks for the most relevant guides from the eToro Academy
Top Dividend Stocks for 2025
Top Dividend Stocks for 2025
Gear up for 2025 with these top dividend stocks. Dive into the potential of Verizon, Exxon Mobil, NextEra, Coca Cola, Unicredit through eToro’s expert analysis.
Read More
Stock Trading And Investing For Beginners
Stock Trading And Investing For Beginners
New to online trading? Learn the basics with eToro. What are stocks? trading vs. investing, what are the risks, and how to open a trade, step by step.
Read More
AI Stocks Poised for Growth in 2025
AI Stocks Poised for Growth in 2025
Gear up for 2025 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.
Read More
Go to the Academy >
Graph
Buy CRISPR Therapeutics AG
Invest in CRISPR Therapeutics AG
Today
Create an eToro account to buy CRSP stock on a secure, user-friendly, multi-asset trading platform.
Buy CRSP

FAQ

The current price of CRSP is ‎$‎61.67.
The average price target for CRISPR Therapeutics AG is ‎$‎82.25. Sign up to eToro for detailed analyst forecasts and price targets.
Analysts offer forecasts for CRISPR Therapeutics AG based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.
The market capitalisation of CRISPR Therapeutics AG is ‎$‎5.61B
Based on 4 analysts offering recommendations for CRSP in the last 3 months, the overall consensus is Moderate Buy.
Daily Movers
Explore the biggest stocks movers on the market.
English (UK)Check icon
Deutsch
Français
Polski
Português
Dansk
Suomi
Español
Русский
العربية
Nederlands
Svenska
Română
Italiano
中文
繁體中文
Norsk
Čeština
Tiếng Việt
Scroll to top